RUNX1 can be a master transcription variable that regulates the expression of various genes necessary for hematopoiesis. Studies implied which the RUNX1 - "Our study exposed the important part of the KLF16/MYC regulatory axis in modulating tumor progress and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, like OTX015 https://abbv-744anditsimpactongen91356.blognody.com/32919348/5-easy-facts-about-abbv-744-combination-therapy-with-chemotherapy-described